STIM

#3505
Neuronetics, Inc. - Common Stock
1.5 4 USD
-1.28%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.54
1.54
Faixa anual
0.80
4.82
Mudança diária
-1.28%
Mudança mensal
-9.41%
Mudança em 6 meses
+3.36%
Mudança anual
-60.71%
Fechamento anterior
1.5 6
Open
1.5 4
Mínimo
1.5 4
High
1.5 4
Volume
33
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 107.17 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Diagnósticos e pesquisa
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-2.34
Índice preço/fluxo de caixa
0.65

Neuronetics, Inc. - Common Stock

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Notícias